Table 3 Clinicopathological parameters and responses to chemotherapy with urine TFF3 in gastric cancer patients

Age

 ≤60

24

4.76 ± 0.72

0.089

 >60

22

8.33 ± 1.99

Gender

 Male

36

6.82 ± 1.30

0.529

 Female

10

5.20 ± 1.21

Site

 Fundus/Cardia

18

6.26 ± 1.23

 Gastric body

16

8.47 ± 2.54

0.087

 Antrum

12

4.10 ± 0.99

Degree of differentiation

 Well-moderately

27

6.35 ± 0.93

0.898

 Poorly

19

6.63 ± 2.20

Stage

(I-III VS IV)

0.414

 I-II

9

4.15 ± 0.59

 III

5

6.40 ± 4.10

 IV

32

7.12 ± 1.36

Lymphatic metastasis

 N(-)

6

4.23 ± 0.79

0.743

 N(+)

9

7.12 ± 1.36

Distant metastasis

 M0

14

4.96 ± 1.44

0.346

 M1

32

7.12 ± 1.36

Responses to chemotherapy

 PR

6

  Befor-chemo

8.53 ± 1.93

0.189

  After-chemo

5.63 ± 0.72

 SD

9

  Befor-chemo

5.93 ± 0.94

0.76

  After-chemo

6.44 ± 1.35

 PD

9

  Befor-chemo

6.02 ± 1.68

0.053

  After-chemo

23.05 ± 7.44